IPO Alert: Virios Therapeutics (VIRI)
IPO Alert: Virios Therapeutics (VIRI) WASHINGTON (dpa-AFX) - Alpharetta, Georgia-based Virios Therapeutics Inc is set to make its stock market debut on the Nasdaq Capital Market on December 17, 2020 under the ticker symbol 'VIRI.' Virios is a clinical-stage biotechnology company developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia. The company has offered to sell 3 million shares of its common stock in the public offering at a price of $10 each. The underwriters have a 45-day option to purchase up to an additio...